Gilead’s Remdesivir Gains Orphan Drug Status as Possible COVID-19 Treatment By Sam | March 24, 2020 The FDA has granted Gilead’s remdesivir orphan drug designation as a potential treatment for COVID-19. Source: Devices & Diagnostics Letter Posted in Devices & Diagnostics Letter